14:59 Nov 08
Emcure Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Emcure Pharmaceuticals Ltd.
Industry Pharmaceuticals
14:59 Nov 08
Quality
55/100
High Financial Strength
Valuation
28/100
Expensive Valuation
Technical
36/100
Technically Neutral
Strength
6
Weakness
6
Opportunity
0
Threats
1
16.87 %
ROE %
6.38 %
ROA %
30.00
EPS
172.33
BVPS
7.48 %
Net Profit Margin
| Mar 2022 | Mar 2023 | Mar 2024 | TTM 2024 | ||
|---|---|---|---|---|---|
| Net Sales | 5855.39 | 5985.81 | 6658.25 | 7256.12 | |
| Operating Expenses + | 4525.47 | 4804.63 | 5428.52 | 5933.87 | |
| Raw Material | 2378.55 | 2193.83 | 2665.61 | 3091.45 | |
| Increase Decrease in Cost | -145.4 | 66.69 | -190.19 | -326.95 | |
| Other Manufacturing Expense | 0 | 0 | 0 | 0 | |
| Employee Cost | 1011.82 | 1117.33 | 1292.08 | 1376.58 | |
| Miscellaneous Expenses | 3445.4 | 3521.26 | 4325.98 | 1792.79 | |
| Operating Profit | 1329.92 | 1181.18 | 1229.73 | 1322.25 | |
| Other Income | 63.47 | 45.9 | 56.99 | 99.77 | |
| Depreciation | 244.86 | 260.12 | 312.41 | 380.55 | |
| Interest | 175.98 | 213.61 | 237.15 | 216 | |
| Profit before tax and exceptio.. | 972.55 | 753.36 | 737.16 | 825.47 | |
| Exceptional Items | 0 | -6.15 | -9.93 | -6.8 | |
| PBT | 972.55 | 747.22 | 727.23 | 832.27 | |
| Provision for Taxation | 269.99 | 185.37 | 199.65 | 223.77 | |
| Net Profit | 702.56 | 561.84 | 527.58 | 594.92 | |
| NET Profit after MI | 662.2 | 532.02 | 498.18 | 567.27 | |
| EPS | 36.62 | 29.42 | 27.54 | 25.3 | |
| Operating Profit Margin (%) | 22.71 | 19.73 | 18.47 | 18.22 | |
| Net Profit Margin (%) | 11.31 | 8.89 | 7.48 | 7.82 |
ShareHolding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Sep 24 | |
|---|---|
| Promoter | 78.10 |
| FII | 2.90 |
| MF | 3.30 |
| Public | 15.00 |
| Others | 0.70 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
